Other function ninds center for clinical research resources
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN271201700064C
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,970,620
Award facts
- Opportunity
-
- RFPNIHNINDS1703 Solicitation number
- NINDS Center for Clinical Research Resources Award Notice · Posted Feb 13, 2017
- Contract value 100% obligated
- $6,970,619.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- Woman-Owned Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$2,282 | |
| Funding Only Action | -$355,642 | |
| Funding Only Action | -$23,636 | |
| Funding Only Action | -$6,284 | |
| Funding Only Action | $130,128 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $966,580 | |
| Funding Only Action | $385,719 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $347,460 | |
| Exercise an Option | $1,409,849 | |
| Exercise an Option | $1,464,389 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,338,064 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $167,280 | |
| Original award | $1,148,994 |
Show all 21
About this award
The National Institute on Drug Abuse awarded a definitive cost-plus-fixed-fee contract to The Emmes Company, LLC for clinical research infrastructure support on September 19, 2017, under a woman-owned small business set-aside, with a ceiling value of $6.97 million and ultimate completion date of September 29, 2022.
The contract funded administrative de-obligation of unexpended and expiring fiscal year 2020 funds in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2025 closing of the period of availability. Place of performance is Rockville, Maryland.
Service Contract Inventory reporting captures the contract's actual government-invoiced labor through fiscal year 2022. Most recent reported fiscal year (FY2022) shows 4.2 FTEs across 8,793 contractor hours. Invoiced amounts rose from $625 thousand in FY2021 (7.3 FTEs, 15,224 hours, $41.08/hr derived rate) to $951 thousand in FY2022 ($108.15/hr derived rate). The prime self-performed all reported hours with no subcontractors in FY2022.
Quick answers
Who was awarded contract HHSN271201700064C?
HHSN271201700064C was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 19, 2017.
How much is contract HHSN271201700064C worth?
The government has obligated $6,970,620 on HHSN271201700064C.
Was contract HHSN271201700064C competed?
The extent of competition for HHSN271201700064C was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Woman-Owned Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award